Company: TELO
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-023970
Chunk: 13

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 1
Chunk 13
---
4.5 (1) 
     - 
  
    Granted 
     50,000  
    $7.0  
     4.1  
     - 
  
    Outstanding as June 30, 2024 
     2,824,057  
    $4.89  
     4.49  
     - 

    Outstanding as December 31, 2024 
     2,814,057  
    $4.97  
     3.49 (2) 
     - 
  
    Granted 
     -  
    $-  
     -  
     - 
  
    Outstanding as June 30, 2025 
     2,814,057  
    $4.97  
     3.0 (2) 
     - 
  
    Exercisable, June 30, 2025 
     2,814,057  
    $4.97  
     3.0 (2) 
     - 

    1)
     
    The
    warrants herein consist of various contractual terms. The warrants herein consist of 2,429,025 warrants issued to Bay Shore Trust
    that have a remaining contractual term of 4.5 years as of December 31, 2023, and 335,032 warrants issued to investors associated
    with the 2023 Private Placement that currently have an indeterminable contractual term. See disclosures below for more information
    on these warrants.

    (2)
     
    The
    warrants herein consist of various contractual terms. The warrants herein consist of 2,429,025 warrants issued to Bay Shore Trust
    that have a remaining contractual term of 2.95 years as of June 30, 2025, 335,032 warrants issued to investors associated with the
    2023 Private Placement that currently have an indeterminable contractual term, and 50,000 warrants issued to underwriters as part
    of the IPO with a remaining contractual life of 2.65 years. See disclosures below for more information on these warrants.

    11

TELOMIR
PHARMACEUTICALS, INC.

NOTES
TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2025

(Unaudited)

Underwriter
warrants

In
connection